The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1/2 study of favezelimab in combination with pembrolizumab for anti–PD-1–naive relapsed or refractory (R/R) classical Hodgkin lymphoma (cHL): An updated analysis.
 
John Timmerman
Honoraria - Kite/Gilead
Consulting or Advisory Role - DAVA Oncology; Kite/Gilead; Oncovalent Therapeutics; Oncovalent Therapeutics
Research Funding - Bristol-Myers Squibb; Kite, a Gilead company; Merck
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
David Lavie
Consulting or Advisory Role - Abbvie; Novartis; Roche; Takeda
Travel, Accommodations, Expenses - Abbvie
 
Borchmann Peter
Consulting or Advisory Role - Amgen; Bristol Myers Squibb Foundation; Merck; Novartis; Roche; Takeda
Research Funding - Amgen (Inst); Merck (Inst); MPI Research (Inst); Novartis (Inst); Roche (Inst); Takeda (Inst)
 
Gareth P. Gregory
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; Clinigen Group; Gilead Sciences; Janssen; MSD; Roche/Genentech; Sandoz-Novartis
Speakers' Bureau - Abbvie; Roche/Genentech
Research Funding - BeiGene; Janssen; Merck
Expert Testimony - Janssen
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Novartis; Roche/Genentech
 
Alex Francisco Herrera
Consulting or Advisory Role - Abbvie; ADC Therapeutics; Adicet Bio; Alimera Sciences; AstraZeneca/MedImmune; Bristol-Myers Squibb; Caribou Biosciences; Genentech/Roche; Genmab; Karyopharm Therapeutics; Merck; Pfizer; Regeneron; Seagen; Takeda; Tubulis GmbH
Research Funding - ADC Therapeutics (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Kite, a Gilead company (Inst); Merck (Inst); Seagen (Inst)
 
Leonard Minuk
No Relationships to Disclose
 
Vladan Vucinic
Honoraria - Amgen; BMS GmbH & Co. KG; Gilead Sciences; Janssen
Consulting or Advisory Role - Amgen; BMS GmbH & Co. KG; Gilead Sciences; Janssen
Travel, Accommodations, Expenses - Amgen; Gilead Sciences; Janssen; Sobi
 
Philippe Armand
Consulting or Advisory Role - ADC Therapeutics; ATB Therapeutics; Bristol-Myers Squibb; Enterome; Foresight Diagnostics; Genentech/Roche; GenMab; Merck Sharp & Dohme; Regeneron
Research Funding - Adaptive Biotechnologies; Adaptive Biotechnologies (Inst); Affimed Therapeutics (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); igm (Inst); Kite, a Gilead company (Inst); Merck Sharp & Dohme (Inst); Roche (Inst)
 
Abraham Avigdor
Consulting or Advisory Role - Abbvie; BMSi; Gilead Sciences; Novartis; Roche; Takeda
Travel, Accommodations, Expenses - Roche
 
Robin Gasiorowski
Honoraria - Abbvie; Astellas Pharma; Gilead Sciences; Janssen; MSD; Novartis; Otsuka; Pfizer
 
Yair Herishanu
Honoraria - Abbvie; AstraZeneca; Lilly; Medison; Roche; Tanssen
Consulting or Advisory Role - Lilly; Medison; Tanssen
Research Funding - Tanssen
 
Colm Keane
Honoraria - Beigene; Gilead Sciences; MSD Oncology; Roche
Research Funding - BeiGene; MSD Oncology
 
John Kuruvilla
Honoraria - Abbvie; Amgen; AstraZeneca; BeiGene; Bristol-Myers Squibb; Celgene; Gilead Sciences; Janssen; Karyopharm Therapeutics; Merck; Novartis; Pfizer; Roche; Seagen
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Gilead Sciences; Karyopharm Therapeutics; Merck; Monte Rosa Therapeutics; Roche; Seagen
Research Funding - AstraZeneca; Merck; Roche
Other Relationship - Karyopharm Therapeutics
 
Rachel Marceau West
Employment - Merck
 
Pallavi Pillai
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Patricia Marinello
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Nathalie A. Johnson
Honoraria - Merck; Roche
Consulting or Advisory Role - Abbvie; Gilead Sciences; Merck; Roche